Acknowledgements
We would like to thank the ITREMA participants and investigators. The ITREMA trial was supported by the Netherlands Organisation for Health Research and Development (ZonMW) and NWO-WOTRO Science for Global Development (Grant No: 205300004) and the ZONMW VIMP (Grant No: 2053000041). This sub-study was supported by the Consortium for Advanced Research Training in Africa (CARTA). CARTA is jointly led by the African Population and Health Research Center and the University of the Witwatersrand. The statements and views made in this article are solely the responsibility of the authors.